Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Alvotech (NASDAQ: ALVO) today announced the availability of SELARSDI™ (ustekinumab-aekn) ...
Researchers have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of combination therapies for complex diseases. The study ...
Researchers from the National University of Singapore (NUS) have pioneered a new catalytic transformation that converts ...
Precise calculations of binding free energy are pivotal in reducing the high costs and inefficiencies of drug discovery. A recent study presents PairMap, an innovative computational tool that ...
In the medical device industry, FDA inspections are not a regulatory hurdle — they are a powerful tool for improving product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback